Process View
The process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotube differentiation starts with myoblast fusion and the appearance of specific cell markers (this is the cell development step). Then individual myotubes can fuse to form bigger myotubes and start to contract. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "myotube differentiation"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
EGFR | epidermal growth factor receptor | 0.994 | ||
YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.992 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.983 | ||
HDAC4 | histone deacetylase 4 | 0.755 | ||
IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.608 | ||
CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.604 | Human | |
NOTCH1 | notch 1 | 0.551 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.550 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.386 | ||
JAG1 | jagged 1 | 0.362 | ||
CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.334 | Human | |
AR | androgen receptor | 0.301 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.297 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.294 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.242 | ||
TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.240 | ||
YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.221 | ||
PSG9 | pregnancy specific beta-1-glycoprotein 9 | 0.210 | Human | |
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.197 | ||
NCK1 | NCK adaptor protein 1 | 0.192 | Fly | |
NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.184 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.157 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.157 | Zebrafish | |
RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.149 | ||
NCOR2 | nuclear receptor corepressor 2 | 0.149 | ||
TTN | titin | 0.146 | ||
ATXN1 | ataxin 1 | 0.140 | ||
DOCK1 | dedicator of cytokinesis 1 | 0.130 | Fly | |
ESR1 | estrogen receptor 1 | 0.117 | ||
TBX5 | T-box 5 | 0.117 | Human | |
YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.117 | ||
MEF2C | myocyte enhancer factor 2C | 0.117 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.116 | Zebrafish | |
SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.108 | ||
KAT2B | K(lysine) acetyltransferase 2B | 0.092 | ||
CREBBP | CREB binding protein | 0.090 | ||
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.086 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.085 | ||
FSTL1 | follistatin-like 1 | 0.074 | ||
BMPR1A | bone morphogenetic protein receptor, type IA | 0.074 | ||
IGF2R | insulin-like growth factor 2 receptor | 0.073 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.064 | ||
CEACAM5 | carcinoembryonic antigen-related cell adhesion molecule 5 | 0.064 | ||
YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.063 | ||
MYH7B | myosin, heavy chain 7B, cardiac muscle, beta | 0.060 | ||
ACTR2 | ARP2 actin-related protein 2 homolog (yeast) | 0.059 | ||
ITSN1 | intersectin 1 (SH3 domain protein) | 0.059 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.058 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.057 | Mouse | |
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.056 | ||
GGA2 | golgi-associated, gamma adaptin ear containing, ARF binding protein 2 | 0.055 | ||
NCOR1 | nuclear receptor corepressor 1 | 0.053 | ||
PTRF | polymerase I and transcript release factor | 0.053 | ||
IRS1 | insulin receptor substrate 1 | 0.049 | ||
ALDOA | aldolase A, fructose-bisphosphate | 0.047 | ||
LDHA | lactate dehydrogenase A | 0.046 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.042 | ||
SH3BP2 | SH3-domain binding protein 2 | 0.040 | ||
LAT | linker for activation of T cells | 0.039 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.037 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.037 | ||
RABEP1 | rabaptin, RAB GTPase binding effector protein 1 | 0.037 | ||
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.036 | ||
PSG6 | pregnancy specific beta-1-glycoprotein 6 | 0.036 | Human | |
ARPC5 | actin related protein 2/3 complex, subunit 5, 16kDa | 0.036 | ||
TRIM63 | tripartite motif containing 63 | 0.036 | ||
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.035 | Fly | |
WIPF1 | WAS/WASL interacting protein family, member 1 | 0.035 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.035 | ||
PRKD2 | protein kinase D2 | 0.034 | ||
JUN | jun proto-oncogene | 0.034 | ||
FLNA | filamin A, alpha | 0.034 | ||
MYL9 | myosin, light chain 9, regulatory | 0.034 | ||
YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.034 | ||
RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.033 | Fly | |
BCL6 | B-cell CLL/lymphoma 6 | 0.033 | ||
PSG4 | pregnancy specific beta-1-glycoprotein 4 | 0.033 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.033 | Fly | |
IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.032 | Human | |
ARPC2 | actin related protein 2/3 complex, subunit 2, 34kDa | 0.032 | ||
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.032 | ||
ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.032 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.032 | ||
ATF3 | activating transcription factor 3 | 0.031 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.031 | ||
UTRN | utrophin | 0.031 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.031 | ||
RBFOX2 | RNA binding protein, fox-1 homolog (C. elegans) 2 | 0.030 | ||
VAV1 | vav 1 guanine nucleotide exchange factor | 0.030 | Fly | |
DTNA | dystrobrevin, alpha | 0.030 | ||
SMAD3 | SMAD family member 3 | 0.029 | ||
GAB1 | GRB2-associated binding protein 1 | 0.029 | ||
SYNRG | synergin, gamma | 0.029 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.028 | ||
SMAD1 | SMAD family member 1 | 0.028 | ||
TESK1 | testis-specific kinase 1 | 0.028 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.027 | ||
ELMO1 | engulfment and cell motility 1 | 0.027 | Fly | |
FBLN1 | fibulin 1 | 0.027 | ||
JUND | jun D proto-oncogene | 0.026 | ||
LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.026 | ||
IL2RG | interleukin 2 receptor, gamma | 0.026 | ||
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.025 | ||
PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.025 | ||
UBASH3B | ubiquitin associated and SH3 domain containing B | 0.025 | ||
PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.024 | Human | |
FN1 | fibronectin 1 | 0.024 | ||
CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | 0.024 | ||
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.024 | ||
COASY | CoA synthase | 0.024 | ||
CNOT8 | CCR4-NOT transcription complex, subunit 8 | 0.024 | ||
PSG1 | pregnancy specific beta-1-glycoprotein 1 | 0.023 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.023 | ||
CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.023 | ||
EP300 | E1A binding protein p300 | 0.023 | ||
ABI1 | abl-interactor 1 | 0.023 | ||
GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.023 | Fly | |
PGK1 | phosphoglycerate kinase 1 | 0.023 | ||
MTMR12 | myotubularin related protein 12 | 0.022 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.022 | Human | |
ITGB1BP3 | integrin beta 1 binding protein 3 | 0.022 | ||
PGAM1 | phosphoglycerate mutase 1 (brain) | 0.021 | ||
IGFBP4 | insulin-like growth factor binding protein 4 | 0.021 | Human | |
RANBP9 | RAN binding protein 9 | 0.020 | ||
FHL2 | four and a half LIM domains 2 | 0.020 | ||
FOXO3 | forkhead box O3 | 0.020 | Fly | |
GPI | glucose-6-phosphate isomerase | 0.019 | ||
NCOA6 | nuclear receptor coactivator 6 | 0.019 | ||
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.019 | ||
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.018 | ||
SIRT1 | sirtuin 1 | 0.018 | ||
CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.018 | ||
BCL2L1 | BCL2-like 1 | 0.018 | ||
GGA1 | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 | 0.018 | ||
PTCH1 | patched 1 | 0.018 | ||
NLRC4 | NLR family, CARD domain containing 4 | 0.018 | ||
HCK | hemopoietic cell kinase | 0.017 | ||
ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.017 | ||
DLL1 | delta-like 1 (Drosophila) | 0.017 | ||
CAST | calpastatin | 0.017 | ||
SYK | spleen tyrosine kinase | 0.017 | ||
SOS1 | son of sevenless homolog 1 (Drosophila) | 0.017 | ||
SMAD4 | SMAD family member 4 | 0.017 | ||
PAX8 | paired box 8 | 0.017 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.017 | ||
PNRC1 | proline-rich nuclear receptor coactivator 1 | 0.017 | ||
HDAC9 | histone deacetylase 9 | 0.016 | Human Mouse | |
PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.016 | ||
DMD | dystrophin | 0.016 | Mouse | |
PLCG1 | phospholipase C, gamma 1 | 0.016 | ||
CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.016 | Human | |
PSG3 | pregnancy specific beta-1-glycoprotein 3 | 0.016 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.016 | ||
NOTCH3 | notch 3 | 0.016 | Human | |
ARPC3 | actin related protein 2/3 complex, subunit 3, 21kDa | 0.015 | ||
ARPC1B | actin related protein 2/3 complex, subunit 1B, 41kDa | 0.015 | ||
VCL | vinculin | 0.015 | ||
GRB10 | growth factor receptor-bound protein 10 | 0.015 | ||
VAV2 | vav 2 guanine nucleotide exchange factor | 0.015 | Fly | |
GATA4 | GATA binding protein 4 | 0.015 | ||
SH3RF1 | SH3 domain containing ring finger 1 | 0.014 | ||
GAB2 | GRB2-associated binding protein 2 | 0.014 | ||
ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.014 | ||
INO80B | INO80 complex subunit B | 0.014 | ||
ACTB | actin, beta | 0.014 | ||
ZYX | zyxin | 0.014 | ||
PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.013 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.013 | ||
H3F3C | H3 histone, family 3C | 0.013 | ||
MDFI | MyoD family inhibitor | 0.013 | ||
PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.013 | ||
RARA | retinoic acid receptor, alpha | 0.013 | ||
NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 0.013 | ||
NCOA2 | nuclear receptor coactivator 2 | 0.013 | ||
HDAC5 | histone deacetylase 5 | 0.013 | ||
FOXP3 | forkhead box P3 | 0.013 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.013 | ||
TMOD3 | tropomodulin 3 (ubiquitous) | 0.013 | ||
MYOZ1 | myozenin 1 | 0.012 | ||
GNAI3 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 | 0.012 | ||
EMP3 | epithelial membrane protein 3 | 0.012 | ||
DTNB | dystrobrevin, beta | 0.012 | ||
WDR1 | WD repeat domain 1 | 0.012 | ||
PPARA | peroxisome proliferator-activated receptor alpha | 0.012 | ||
TCF4 | transcription factor 4 | 0.012 | ||
SORL1 | sortilin-related receptor, L(DLR class) A repeats containing | 0.012 | Human | |
DDR1 | discoidin domain receptor tyrosine kinase 1 | 0.012 | ||
CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.012 | ||
MYOD1 | myogenic differentiation 1 | 0.012 | ||
ZHX1 | zinc fingers and homeoboxes 1 | 0.012 | ||
PARVA | parvin, alpha | 0.012 | ||
AXL | AXL receptor tyrosine kinase | 0.011 | ||
EXOC5 | exocyst complex component 5 | 0.011 | ||
TNKS2 | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 | 0.011 | ||
TF | transferrin | 0.011 | ||
CSK | c-src tyrosine kinase | 0.011 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.011 | ||
RHOU | ras homolog gene family, member U | 0.011 | ||
PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.011 | ||
HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.011 | ||
USP14 | ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) | 0.011 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.011 | ||
HSPB2 | heat shock 27kDa protein 2 | 0.011 | ||
DBP | D site of albumin promoter (albumin D-box) binding protein | 0.011 | ||
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.011 | ||
CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.011 | Human | |
S100A6 | S100 calcium binding protein A6 | 0.011 | ||
STK10 | serine/threonine kinase 10 | 0.010 | ||
RBPMS | RNA binding protein with multiple splicing | 0.010 | ||
BTF3 | basic transcription factor 3 | 0.010 | ||
MEF2A | myocyte enhancer factor 2A | 0.010 | Human Fly | |
RUNX1 | runt-related transcription factor 1 | 0.010 | ||
MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.010 | ||
RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.010 | ||
SORT1 | sortilin 1 | 0.010 | ||
OSTF1 | osteoclast stimulating factor 1 | 0.010 |